DIMENSIONAL FUND ADVISORS LP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 354204
AUSTIN, TX
Position in REGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$396,410,676
+$10,827,651 QoQ
Shares Held
513,060
+2.7% QoQ
Ownership
0.489%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 79.28526877947998.ToString("F0")%
Shared 10.825634428721786.ToString("F0")%
None 9.889096791798229.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. REGN ranks #2 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $396,410,676 | 513,060 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $385,583,025 | 499,544 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $280,626,705 | 499,096 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $272,704,425 | 519,437 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $362,263,928 | 571,187 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $418,155,515 | 587,025 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $599,274,077 | 570,064 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $616,494,257 | 586,562 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $566,861,371 | 588,953 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $521,284,435 | 593,522 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $509,631,145 | 619,266 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $440,338,555 | 612,824 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $520,534,515 | 633,508 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $457,848,894 | 634,588 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $448,045,867 | 650,407 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $373,538,591 | 631,906 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $408,679,764 | 585,149 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $317,337,536 | 502,498 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $244,208,285 | 403,530 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $178,874,669 | 320,254 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $118,354,551 | 250,147 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $114,421,221 | 236,843 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $125,874,929 | 224,865 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $134,960,978 | 216,405 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $102,155,150 | 209,210 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||